10-Q//Quarterly update
NUCRYST Pharmaceuticals Corp. 10-Q
Accession 0001279569-09-001450
CIK 0001344674operating
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 13, 6:19 PM ET
Size
696.1 KB
Accession
0001279569-09-001450
Documents
- 10-Qnucryst10q.htmPrimary
FORM 10-Q
- EX-31.1ex311.htm
CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.
- EX-32.1ex321.htm
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
Issuer
NUCRYST Pharmaceuticals Corp.
CIK 0001344674
Entity typeoperating
IncorporatedAlberta, Canada
Related Parties
1- filerCIK 0001344674
Filing Metadata
- Form type
- 10-Q
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 13, 6:19 PM ET
- Size
- 696.1 KB